Literature DB >> 12147293

Endothelin-1-induced arachidonic acid release by cytosolic phospholipase A2 activation in rat vascular smooth muscle via extracellular signal-regulated kinases pathway.

Lucia Trevisi1, Sergio Bova, Gabriella Cargnelli, Giulio Ceolotto, Sisto Luciani.   

Abstract

The present study investigates whether endothelin-1 (ET-1), like noradrenaline (NA), stimulates the release of arachidonic acid (AA) via cytosolic phospholipase A2 (cPLA2) in rat tail artery. In tail artery segments labelled with [3H]AA, ET-1-induced AA release in a concentration-dependent manner with an EC50 of 1.3 nM. The effect of ET-1 was inhibited by bosentan and was insensitive to BQ788, suggesting the involvement of ETA receptor. The stimulation of AA release induced by ET-1 was prevented by arachydonyl trifluoromethyl ketone (AACOCF3), a selective inhibitor of cPLA2 and not by RHC80267, a diacylglycerol lipase inhibitor. Furthermore, PD98059, inhibitor of mitogen-activated protein kinase kinase (MEK) cascade and calphostin C, a protein kinase C (PKC) inhibitor, prevented the stimulation of AA release induced by ET-1 and NA. Immunoblotting of the cytosolic fraction of rat tail arteries stimulated with ET-1 or NA showed an increase in extracellular signal-regulated kinases (ERKs) phosphorylation and this effect was abolished by calphostin C treatment. These findings show that in rat tail artery ET-1 and NA induce a sequential activation of protein kinase C and extracellular signal-regulated kinases that results in stimulation of AA release via cPLA2 activation. This may represent a general pathway by which G-proteins coupled receptors stimulate AA release and its metabolites in vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147293     DOI: 10.1016/s0006-2952(02)01066-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology.

Authors:  Nayaab S Khan; Chi Young Song; Brett L Jennings; Anne M Estes; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

2.  Contribution of Ras farnesyl transferase, MAP kinase and cytochrome P-450 metabolites to endothelin-1 induced hypertension.

Authors:  Farid Ljuca; Gorazd Drevenšek; Enver Zerem
Journal:  Bosn J Basic Med Sci       Date:  2011-05       Impact factor: 3.363

Review 3.  Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.

Authors:  Kafait U Malik; Brett L Jennings; Fariborz A Yaghini; Seyhan Sahan-Firat; Chi Young Song; Anne M Estes; Xiao R Fang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-12-20       Impact factor: 3.072

Review 4.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

5.  Endothelin-1 induced vascular smooth muscle cell proliferation is mediated by cytochrome p-450 arachidonic acid metabolites.

Authors:  Farid Ljuca; Gorazd Drevensek
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

6.  Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop.

Authors:  Karl Deacon; Alan J Knox
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

7.  Possible involvement of Ca2+-independent phospholipase A2 in protease-activated receptor-2-mediated contraction of rat urinary bladder.

Authors:  Yuko Kubota; Tsutomu Nakahara; Akiko Mitani; Takeshi Maruko; Maki Saito; Kenji Sakamoto; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-15       Impact factor: 3.000

8.  Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.

Authors:  Brett L Jennings; Anne M Estes; Larry J Anderson; Xiao R Fang; Fariborz A Yaghini; Zheng Fan; Frank J Gonzalez; William B Campbell; Kafait U Malik
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

9.  TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension.

Authors:  Yang Xia; Zhenzhen Fu; Jinxing Hu; Chun Huang; Omkar Paudel; Shaoxi Cai; Wolfgang Liedtke; James S K Sham
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-05       Impact factor: 4.249

10.  Involvement of extracellular Ca2+ influx and epidermal growth factor receptor tyrosine kinase transactivation in endothelin-1-induced arachidonic acid release.

Authors:  Yoshifumi Kawanabe; Kazuhiko Nozaki; Nobuo Hashimoto; Tomoh Masaki
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.